CARPENTER CHRISTOPHER L. 4
4 · Rubius Therapeutics, Inc. · Filed Jun 24, 2019
Insider Transaction Report
Form 4
CARPENTER CHRISTOPHER L.
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2019-06-20$2.87/sh+243$697→ 35,086 total - Sale
Common Stock
2019-06-20$13.93/sh−243$3,386→ 34,843 total - Exercise/Conversion
Stock Option (Right to Buy)
2019-06-20−243→ 619,157 totalExercise: $2.87Exp: 2027-10-24→ Common Stock (243 underlying)
Footnotes (3)
- [F1]The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.79 to $14.03, inclusive. The reporting person undertakes to provide to Rubius Therapeutics, Inc., any security holder of Rubius Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F3]25% of this option shall vest on September 18, 2018, then in 12 equal quarterly installments thereafter.